DOWNLOAD :/uploadfile/file/20171120/20171120161128_30335.xlsx
No |
API Name |
CAS |
Indication |
API |
Formulation |
Progress |
Brand Company |
Qualifications |
1 |
Bisoprolol Fumarate |
104344-23-2 |
Hypotensor |
available |
2.5mg、 5mg/Tab |
Approved By CFDA |
Merck |
GMP |
2 |
Candesartan Cilexetil |
145040-37-5 |
Hypotensor |
available |
4mg、8mg/Tab |
Approved By CFDA |
AZ |
GMP |
3 |
Roxatidine acetate hydrochloride |
93793-83-0 |
Gastric ulcer |
available |
75mg/Inj |
Approved By CFDA |
Nippo zoki |
GMP |
4 |
Oxcarbazepine |
28721-07-5 |
Antiepileptic |
available |
150mg、200mg/Tab |
Approved By CFDA |
Novartis |
GMP |
5 |
Vinpocetine |
42971-09-5 |
Cerebral circulation |
available |
5ml:30mg/Inj |
To Be Approved |
Gedeon Richter |
GMP |
6 |
Flupirtine Maleate |
75507-68-5 |
Painkillers |
available |
100mg/Cap |
To Be Approved |
AWD |
GMP |
7 |
Lafutidine |
118288-08-7 |
Gastric ulce |
available |
5mg、10mg/Tab |
To Be Approved |
TAIHO |
GMP |
8 |
Ticagrelor |
274693-27-5 |
Anticoagulant |
available |
90mg/Tab |
To Be Approved |
AZ |
GMP |
9 |
Olopatadine Hydrochloride |
140462-76-6 |
allergy |
available |
5ml:5mg/Drops |
To Be Approved |
Alcon |
GMP |
10 |
Zolmitriptan |
139264-17-8 |
migraine |
available |
2.5mg/Cap |
To Be Approved |
AZ |
GMP |
11 |
Febuxostat |
144060-53-7 |
Anti gout |
available |
80mg、120mg/Tab |
To Be Approved |
Takeda |
GMP |
12 |
Pregabalin |
148553-50-8 |
Antiepileptic |
available |
25mg、75mg/Cap |
To Be Approved |
Pfizer |
GMP |
13 |
Ornithine Aspartate |
3230-94-2 |
Lliver protection |
available |
2.5g/Inj |
To Be Approved |
Merz |
GMP |
14 |
Clopidogrel bisulphate |
135046-48-9 |
Anticoagulant |
available |
75mg/Tab |
To Be Approved |
Sanofi |
GMP |
15 |
Duloxetine hydrochloride |
136434-34-9 |
Antidepressant |
available |
20mg/Cap |
To Be Approved |
Lilly |
GMP |
16 |
Paliperidone Palmitate |
199739-10-1 |
Schizophrenia |
available |
1.0ml:100mg/Inj |
To Be Approved |
Janssen |
GMP |
17 |
Prasugrel Hydrochloride |
389574-19-0 |
Anticoagulant |
available |
5mg、7.5mg/Tab |
To Be Approved |
Lilly |
GMP |
18 |
Tenofovir Alafenamide Fumarate |
1392275-56-7 |
Hepatitis B drugs |
available |
25mg/Tab |
To Be Approved |
Glead |
Non-GMP product qualification under GMP plant |
19 |
Sofosbuvir |
1190307-88-0 |
Hepatitis C drugs |
available |
400mg/Tab |
To Be Approved |
Glead |
Non-GMP product qualification under GMP plant |
20 |
Lacosamide |
175481-36-4 |
Antiepileptic |
available |
20ml:200mg/Inj |
To Be Approved |
UCB |
Non-GMP product qualification under GMP plant |
21 |
Dabigatran etexilate mesylate |
872728-81-9 |
Anticoagulant |
available |
75mg、150mg/Cap |
To Be Approved |
BI |
Non-GMP product qualification under GMP plant |
22 |
Parecoxib Sodium |
198470-85-8 |
Surgical pain killer |
available |
20mg、40mg/Inj |
To Be Approved |
Pfizer |
Non-GMP product qualification under GMP plant |
23 |
Azilsartan medoxomil |
863031-21-4 |
Hypotensor |
available |
20mg、40mg/Tab |
To Be Approved |
Takeda |
Non-GMP product qualification under GMP plant |
24 |
Erlotinib Hydrochloride |
183319-69-9 |
Lung cancer |
available |
25mg、100mg、150mg/Tab |
To Be Approved |
Roche |
Non-GMP product qualification under GMP plant |
Tel: +86 0871 6511 0906 (GMT+8 AM9:00-AM:12:00 PM1:30-PM6:00)
cell phone:188 1221 6310
Fax:0871-63602606
Email: info@luhancn.com
Address:Room 3301,33rd Floor Building B, Vogue Garden Plaza, No.1004 Beijing Road, Kunming, Yunnan Province, P. R. China 650000